biolreprod.org/cgi/content/full/71/5/1568
Gene Transfer of Inducible Nitric Oxide Synthase Complementary
DNA Regresses the Fibriotic Plaque in an Animal Model of
Peyronie’s Disease.
Davila HH, Magee TR, Vernet D, Rajfer J,
Gonzalez-Cadavid NF.
To investigate the antifibrotic role of inducible
nitric oxide synthase (iNOS) in Peyronie’s disease
(PD), by determining whether a plasmid expressing
inducible nitric oxide synthase (piNOS) injected into
a PD-like plaque can induce regression of the plaque.
A PD like plaque was induced with fibrin in the penile
tunica albuginea (TA) of mice, and then injected with
a luciferase-expressing plasmid (pLuc), either alone
or with piNOS, following luciferase expression in vivo
by bioluminescence imaging.
Rats were treated with either piNOS, an empty control plasmid (pC), or
saline. Other groups were treated with pC or piNOS, in
the absence of fibrin. Tissue sections were stained
for collagen, transforming growth factor (TGF-beta1)
and plasminogen activator inhibitor (PAI-1) as
pro-fibrotic factors, CuZn superoxide dismutase (SOD)
and nitrotyrosine to detect NO reaction with reactive
oxygen species (ROS).
Quantitative image analysis was applied. iNOS and xanthine oxido-reductase (XOR) (oxidative stress) were estimated by western blot.
Luciferase reporter expression was restricted to the
penis and peaked at 3 days after injection but
continued for at least 3 weeks. In rats receiving
piNOS, iNOS expression also peaked at 3 days, but
decreased at the end of treatment when a considerable
reduction of plaque size occurred.
Protein nitrotyrosine, XOR, and SOD increased, and TGF-beta1
and PAI-1, decreased.
piNOS gene transfer regressed the PD plaque and expression of profibrotic factors, supporting the view that endogenous iNOS induction in
PD is defense mechanism by the tissue against fibrosis.
PMID: 15240426 [PubMed - as supplied by publisher]